Rory Smoot

16PUBLICATIONS
59CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 03, 2026
TNK1 is a targetable JAK-independent driver of STAT signaling and inflammation.

|Jun 11, 2026
Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patients.

|Jun 11, 2026
Transplantation for unresectable perihilar cholangiocarcinoma beyond the Mayo protocol: a challenge for SURE.

|Feb 06, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinoma.

Hendrien Kuipers, Danielle M Carlson, Erik Jessen

|Jul 22, 2025
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm.

Oluwadunni E Emiloju, Nathan R Foster, Bahar Saberzadeh Ardestani

|Mar 10, 2025
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor role.

Evodie Koutouan, Ayano Niibe, Jack W Sample

Pageof 3

Frequent Collaborators

3 joint publications

Patrick Starlinger

2 joint publications

Chen Wang

2 joint publications

Gregory J Gores

2 joint publications

Hendrien Kuipers